Tuberculosis and substance abuse in the United States, 1997-2006
- PMID: 19171816
- DOI: 10.1001/archinternmed.2008.535
Tuberculosis and substance abuse in the United States, 1997-2006
Abstract
Background: Tuberculosis (TB) control efforts are often ineffective in controlling TB among patients who use illicit drugs or abuse alcohol (substance abuse). This study examined the prevalence of substance abuse among TB cases reported in the United States and assessed the relation between substance abuse and indicators of TB transmission.
Methods: A cross-sectional analysis was performed of data on US TB cases in patients 15 years or older reported from 1997 through 2006. Analyses included number and proportion of patients with TB characterized by substance abuse and associations between substance abuse, sputum smear status, treatment failure, and inclusion in a county-level genotype cluster.
Results: Of 153,268 patients with TB, 28,650 (18.7%) reported substance abuse, including 22,293 of 76,816 US-born patients (29.0%). Multivariate analysis showed that, among patients negative for human immunodeficiency virus, odds of sputum smear-positive disease were 1.8 (99% confidence interval [CI], 1.7-1.9) times greater among those who reported substance abuse; this association was weaker among patients with human immunodeficiency virus infection (odds ratio [OR], 1.2; 99% CI, 1.1-1.4). Among female patients, odds of treatment failure were 2.4 (99% CI, 1.9-3.0) times greater among those who reported substance abuse. The association was weaker among male patients (OR, 1.5; 99% CI, 1.3-1.7). Patients who abused substances were more likely to be involved in a county-level genotype cluster (US-born: OR, 2.3; 99% CI, 2.0-2.7; foreign-born: 1.5; 1.2-2.0).
Conclusions: Substance abuse is the most commonly reported behavioral risk factor among patients with TB in the United States. Patients who abuse substances are more contagious (eg, smear positive) and remain contagious longer because treatment failure presumably extends periods of infectiousness. Increased transmission is consistent with our finding that patients who abuse substances were more likely to be involved in a localized genotype cluster, which can represent recent transmission.
Comment in
-
Tuberculosis and substance abuse.Arch Intern Med. 2009 Jul 13;169(13):1245; author reply 1245-6. doi: 10.1001/archinternmed.2009.183. Arch Intern Med. 2009. PMID: 19597078 No abstract available.
Similar articles
-
Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands.Clin Infect Dis. 2008 Nov 1;47(9):1135-42. doi: 10.1086/591974. Clin Infect Dis. 2008. PMID: 18823268
-
Patient and health service delay in pulmonary tuberculosis patients attending a referral hospital: a cross-sectional study.BMC Public Health. 2005 Nov 24;5:122. doi: 10.1186/1471-2458-5-122. BMC Public Health. 2005. PMID: 16307685 Free PMC article.
-
Characteristics of tuberculosis patients who generate secondary cases.Int J Tuberc Lung Dis. 1997 Aug;1(4):352-7. Int J Tuberc Lung Dis. 1997. PMID: 9432392
-
The epidemiology of tuberculosis in the United States.Semin Respir Infect. 1989 Sep;4(3):157-70. Semin Respir Infect. 1989. PMID: 2688000 Review.
-
Risk factors leading to adolescent substance abuse.Adolescence. 1995 Spring;30(117):201-8. Adolescence. 1995. PMID: 7625258 Review.
Cited by
-
Infectious disease comorbidities adversely affecting substance users with HIV: hepatitis C and tuberculosis.J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 1(0 1):S37-42. doi: 10.1097/QAI.0b013e3181f9c0b6. J Acquir Immune Defic Syndr. 2010. PMID: 21045598 Free PMC article.
-
The global burden of tuberculosis: results from the Global Burden of Disease Study 2015.Lancet Infect Dis. 2018 Mar;18(3):261-284. doi: 10.1016/S1473-3099(17)30703-X. Epub 2017 Dec 7. Lancet Infect Dis. 2018. PMID: 29223583 Free PMC article.
-
Universal Genotyping for Tuberculosis Prevention Programs: a 5-Year Comparison with On-Request Genotyping.J Clin Microbiol. 2018 Apr 25;56(5):e01778-17. doi: 10.1128/JCM.01778-17. Print 2018 May. J Clin Microbiol. 2018. PMID: 29540458 Free PMC article.
-
Clinical mimics: an emergency medicine focused review of pneumonia mimics.Intern Emerg Med. 2018 Jun;13(4):539-547. doi: 10.1007/s11739-018-1840-z. Epub 2018 Mar 26. Intern Emerg Med. 2018. PMID: 29582318 Review.
-
Factors associated with recurrent tuberculosis more than 12 months after treatment completion.Int J Tuberc Lung Dis. 2016 Jan;20(1):49-56. doi: 10.5588/ijtld.15.0442. Int J Tuberc Lung Dis. 2016. PMID: 26688528 Free PMC article.